Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design

Author(s): Mazhar Hussain, Muhammad Idrees, Samia Afzal.

Journal Name: Current Computer-Aided Drug Design

Volume 11 , Issue 1 , 2015


Dengue virus (DENV) is the member of Flaviviridae and causative agent of Dengue Haemorrhagic Fever and Dengue Shock Syndrome. Every year, around 70% of the world population is at risk, due to epidemic episodes orchestrated by one or more of its serotypes. So, a tetravalent DENV vaccine is needed which may induce the immune response against all four DENV serotypes. In this study, B-cell and T-cell epitopes have been predicted from the DENV envelope glycoprotein (Eg) using a consensus based approach in complement with the physico-chemical property (PCP) conservancy analysis. Through DENV-Eg analysis, a total of 7 PCP conserved, water soluble, in vitro and in vivo stable epitopes were predicted which may induce the B-cell and T-cell mediated anti-viral immune response.

Keywords: Dengue virus, consensus sequence, Envelope glycoprotein, phylogenetic analysis, in silico design.

Rights & PermissionsPrintExport

Article Details

Year: 2015
Page: [84 - 97]
Pages: 14
DOI: 10.2174/1573409911666150529130134
Price: $58

Article Metrics

PDF: 25
PRC: 0